alanylproline has been researched along with n-valyltryptophan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Ishida, R; Kato, J; Kubo, M; Nunami, K; Ochiai, T; Yoneda, N | 1 |
| He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
2 other study(ies) available for alanylproline and n-valyltryptophan
| Article | Year |
|---|---|
Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carboxylic Acids; Imidazoles; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |